Lvw Advisors, LLC Arcutis Biotherapeutics, Inc. Transaction History
Lvw Advisors, LLC
- $862 Million
- Q2 2025
A detailed history of Lvw Advisors, LLC transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Lvw Advisors, LLC holds 17,561 shares of ARQT stock, worth $271,844. This represents 0.03% of its overall portfolio holdings.
Number of Shares
17,561
Previous 14,466
21.39%
Holding current value
$271,844
Previous $227,000
8.37%
% of portfolio
0.03%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding ARQT
# of Institutions
251Shares Held
126MCall Options Held
605KPut Options Held
170K-
Suvretta Capital Management, LLC New York, NY11.4MShares$177 Million7.82% of portfolio
-
Jennison Associates LLC11.4MShares$176 Million0.13% of portfolio
-
Rubric Capital Management LP New York, NY11MShares$170 Million4.91% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.79MShares$136 Million8.65% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$133 Million0.0% of portfolio
About Arcutis Biotherapeutics, Inc.
- Ticker ARQT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,187,500
- Market Cap $932M
- Description
- Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...